Dan Wright

Associate Professor Dan Wright is an Associate Professor in Clinical Pharmacy at the School of Pharmacy, Faculty of Medicine and Health, University of Sydney. He holds a pharmacy degree from Dalhousie University, an MSc in Clinical Pharmacy, and a PhD from the University of Otago, where his doctoral thesis examined predicting allopurinol dose requirements. Prior to his appointment at Sydney, Wright held positions as Lecturer and Senior Lecturer at the School of Pharmacy, University of Otago, advancing research in clinical pharmacology.

Wright's academic interests center on clinical pharmacology and pharmacometrics, with emphasis on medication adherence, gout management, population pharmacokinetic/pharmacodynamic analyses, and bias assessment in adherence studies. His publications have received 1894 citations, achieving an h-index of 23 on Google Scholar. Key works include 'Risk of bias tools for medication adherence research: RoBIAS and RoBAd' (2025), 'Easing the way to achieving target serum urate in people with gout' (2024), 'Patient-Led Urate Self-Monitoring to Improve Clinical Outcomes in Gout' (2024), 'The development and evaluation of dose-prediction tools for allopurinol in gout' (2024), 'A framework for understanding sources of bias in medication adherence research' (2023, British Journal of Clinical Pharmacology), and 'An allopurinol adherence tool using plasma oxypurinol concentrations' (2022). He serves as Program Director for the Master of Pharmacy, guiding professional training in pharmacy practice. His contributions enhance dosing strategies for urate-lowering therapies and methodological rigor in pharmacotherapy research.

Professional Email: dan.wright@sydney.edu.au